Statistics
Publications
1
Citations
16
H-Index
1
Active since
2022
Affiliations
AZ Delta(Current)
A. Rijneveld is an author at AZ Delta specializing in blinatumomab therapy, b-cell targeted therapy, and molecular oncology.
Publications per year
2022–2022
1
1